OCT 12, 2021 5:30 AM PDT

Tiny Fragments of RNA in the Blood Signal Dementia Risk

WRITTEN BY: Tara Fernandez

Scientists have discovered a novel biomarker in the blood that acts as an early warning sign for dementia: microRNA. These small, single-stranded RNA molecules are a distinct class of biological regulators that orchestrate the way genes are expressed, influencing many complex processes throughout the body.

In a study featured in EMBO Molecular Medicine, researchers led by André Fischer from the German Center for Neurodegenerative Diseases were motivated by finding biological red flags that can signal the potential for dementia onset long before the symptoms begin. 

“Presently, diagnosis happens far too late to even have a chance for effective treatment,” said Fischer. “If dementia is detected early, the odds of positively influencing the course of the disease increase.”

The team used a variety of experimental approaches in their study: animal models, cell cultures, and the analyses of clinical data from both healthy individuals and those with mild cognitive impairment. 

A deep dive revealed a clear pattern—levels of three microRNAs were closely linked to mental fitness levels. Fischer and colleagues also found that patients who had high levels of this biomarker in their blood samples had a 90 percent chance of going on to receive an Alzheimer’s diagnosis within two years. The team estimates that the presence of these microRNAs in circulation is indicative of dementia development within a two- to five-year timeframe.

Interestingly, the three microRNAs are not just clinical biomarkers but also have the potential to be drug targets to slow the neurodegenerative process. Experiments in mouse models of dementia revealed that drugs that specifically blocked these microRNA improved the animals’ learning abilities. “We’ve observed this in mice with age-related mental deficits, as well as in mice with brain damage similar to that occurring in Alzheimer’s disease,” said Fischer.

Ongoing work by the team is focused on translating their findings into a practical, low-cost, easy-to-use test for the microRNA signatures that doctors could deploy during routine medical checkups to catch dementia in their patients earlier.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 31, 2021
Clinical & Molecular DX
Five Questions to Help You Select the Best Cellular Stain
AUG 31, 2021
Five Questions to Help You Select the Best Cellular Stain
Cellular stains are organic fluorescent dyes or fluorescent conjugates designed to localize to a specific organelle or c ...
SEP 14, 2021
Health & Medicine
The Magnitude of Cardiovascular Disease- New Insights and Ways Forward
SEP 14, 2021
The Magnitude of Cardiovascular Disease- New Insights and Ways Forward
Among healthcare professionals, it is common knowledge that cardiovascular disease is the leading cause of death in the ...
SEP 30, 2021
Microbiology
Malaria Parasite Seems to be Evolving to Evade Diagnostic Tests
SEP 30, 2021
Malaria Parasite Seems to be Evolving to Evade Diagnostic Tests
When health officials are trying to control a disease outbreak, diagnostic tests can be a crucial tool that provides inf ...
OCT 04, 2021
Cancer
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
OCT 04, 2021
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
Reports indicate that caffeine consumption in the United States is greatest in adults aged 50 – 64.  Coincide ...
NOV 15, 2021
Health & Medicine
Alpha-synuclein as a Biomarker for Parkinson's Disease
NOV 15, 2021
Alpha-synuclein as a Biomarker for Parkinson's Disease
Parkinson’s disease (PD) is a widespread neurogenerative disorder that can significantly impact a person’s q ...
DEC 01, 2021
Cardiology
Is GDF-15 a Valuable Biomarker for Congestive Heart Failure?
DEC 01, 2021
Is GDF-15 a Valuable Biomarker for Congestive Heart Failure?
Congestive Heart Failure (CHF) is a serious medical condition that results in the heart not being able to pump to meet t ...
Loading Comments...